These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2891954)

  • 21. Thalidomide induction of bone marrow transplantation tolerance.
    Vogelsang GB; Hess AD; Gordon G; Brundrette R; Santos GW
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2658-61. PubMed ID: 3547944
    [No Abstract]   [Full Text] [Related]  

  • 22. Thalidomide for the treatment of chronic graft-versus-host disease.
    Vogelsang GB; Farmer ER; Hess AD; Altamonte V; Beschorner WE; Jabs DA; Corio RL; Levin LS; Colvin OM; Wingard JR
    N Engl J Med; 1992 Apr; 326(16):1055-8. PubMed ID: 1549151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transplantation of T lymphocyte depleted bone marrow to prevent graft-versus-host disease: its implications for fetal liver transplantation.
    Champlin RE; Mitsuyasu RT; Gale RP
    Prog Clin Biol Res; 1985; 193():315-25. PubMed ID: 3911215
    [No Abstract]   [Full Text] [Related]  

  • 24. Bone marrow graft in acute leukemia [proceedings].
    Devergie A; Gluckman E; Marty M; Bussel A
    Pathol Biol (Paris); 1978 Jan; 26(1):45. PubMed ID: 358085
    [No Abstract]   [Full Text] [Related]  

  • 25. Human graft-versus-host disease.
    Parkman R
    Immunodefic Rev; 1991; 2(4):253-64. PubMed ID: 2059433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bullous scleroderma-like changes in chronic graft-versus-host disease.
    Moreno JC; Valverde F; Martinez F; Vélez A; Torres A; Fanego J; Ocaña MS
    J Eur Acad Dermatol Venereol; 2003 Mar; 17(2):200-3. PubMed ID: 12705752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thalidomide responsive chronic pulmonary GVHD.
    Forsyth CJ; Cremer PD; Torzillo P; Iland HJ; Young GA
    Bone Marrow Transplant; 1996 Feb; 17(2):291-3. PubMed ID: 8640183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow transplantation (BMT) for acute lymphoblastic leukemia (ALL) in remission.
    Van Lint MT; Bacigalupo A; Frassoni F; Repetto M; Piaggio G; Congiu M; Vitale V; Scarpati D; Franzone P; Corvò R
    Haematologica; 1986; 71(2):135-8. PubMed ID: 3087834
    [No Abstract]   [Full Text] [Related]  

  • 29. Bone marrow transplantation in acute leukemia--remaining problems.
    Santos GW
    Transplant Proc; 1978 Mar; 10(1):173-5. PubMed ID: 345558
    [No Abstract]   [Full Text] [Related]  

  • 30. A phase-II trial of fractionated total body radiation in bone marrow transplantation for acute leukemia UCLA Bone Marrow Transplant Team.
    Transplant Proc; 1979 Mar; 11(1):205-7. PubMed ID: 377633
    [No Abstract]   [Full Text] [Related]  

  • 31. Extensive chronic graft-versus-host disease of skin successfully treated with thalidomide.
    Nair V; Sharma A; Ghosh I; Arora S; Sahai K; Dutta V
    J Assoc Physicians India; 2005 Nov; 53():988-90. PubMed ID: 16515241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of thalidomide therapy for extramedullary relapse of myeloma following allogeneic transplantation.
    Biagi JJ; Mileshkin L; Grigg AP; Westerman DW; Prince HM
    Bone Marrow Transplant; 2001 Dec; 28(12):1145-50. PubMed ID: 11803357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HL-A and mixed leukocyte culture matched allogeneic bone marrow transplantation in patients with acute leukemia.
    Graw RG; Leventhal BG; Yankee RA; Rogentine GN; Whang-Peng J; Ginnif MH; Herzig GP; Halterman RH; Henderson ES
    Transplant Proc; 1971 Mar; 3(1):405-8. PubMed ID: 4106326
    [No Abstract]   [Full Text] [Related]  

  • 34. Response to thalidomide therapy in refractory chronic graft-versus-host disease.
    Browne PV; Weisdorf DJ; DeFor T; Miller WJ; Davies SM; Filipovich A; McGlave PB; Ramsay NK; Wagner J; Enright H
    Bone Marrow Transplant; 2000 Oct; 26(8):865-9. PubMed ID: 11081386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of established human graft-versus-host disease by antithymocyte globulin.
    Storb R; Gluckman E; Thomas ED; Buckner CD; Clift RA; Fefer A; Glucksberg H; Graham TC; Johnson FL; Lerner KG; Neiman PE; Ochs H
    Blood; 1974 Jul; 44(1):56-75. PubMed ID: 4275768
    [No Abstract]   [Full Text] [Related]  

  • 36. [Transplantation of allogeneic bone marrow treated in vitro with Campath-1 monoclonal antibody].
    Chapuis B; Helg C; Maurice P; Wyss M; Pipard G; Irlé C; Jeannet M
    Schweiz Med Wochenschr; 1985 Oct; 115(43):1521-2. PubMed ID: 3909387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sclerodermatous chronic graft-versus-host disease--a report of four pediatric cases.
    Tolland JP; Devereux C; Jones FC; Bingham EA
    Pediatr Dermatol; 2008; 25(2):240-4. PubMed ID: 18429789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone marrow transplantation in pediatrics.
    Krivit W; Ramsay NK; Woods W; Nesbit M; Filipovich AH; Kim T; Kersey J
    Adv Pediatr; 1983; 30():549-93. PubMed ID: 6369944
    [No Abstract]   [Full Text] [Related]  

  • 39. European experience of bone marrow transplantation for leukemia.
    Ringdén O; Zwaan F; Hermans J; Gratwohl A
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2600-4. PubMed ID: 3547941
    [No Abstract]   [Full Text] [Related]  

  • 40. Thalidomide for chronic graft-versus-host disease in children.
    Heney D; Lewis IJ; Bailey CC
    Lancet; 1988 Dec; 2(8623):1317. PubMed ID: 2904042
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.